In metabolic tissues, particularly adipose and skeletal muscle, ROS impair insulin signaling by altering adipokine profiles (decreased adiponectin and increased leptin/resistin) and by inhibiting key signaling molecules like IRS-1 and GLUT4, resulting in systemic insulin resistance. The gene discussed is IRS1; the disease is Insulin resistance.